Lakewood-Amedex Biotherapeutics Inc (LABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2000 | 03-1999 | 03-1998 | 03-1997 | 03-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 170 | -4,940 | -3,270 | -3,720 | 620 |
| Depreciation Amortization | 4,890 | 4,360 | 770 | 1,060 | 550 |
| Other Working Capital | -3,690 | 3,870 | N/A | N/A | N/A |
| Other Operating Activity | 2,000 | 340 | 2,240 | -1,740 | -720 |
| Operating Cash Flow | $3,370 | $3,630 | $-260 | $-4,400 | $450 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,320 | -1,430 | N/A | N/A | N/A |
| Net Acquisitions | -13,140 | -1,630 | N/A | N/A | N/A |
| Other Investing Activity | 70 | 5,210 | 1,050 | 4,530 | -15,300 |
| Investing Cash Flow | $-14,390 | $2,150 | $1,050 | $4,530 | $-15,300 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 11,640 | -5,980 | -450 | -370 | 15,260 |
| Financing Cash Flow | $11,640 | $-5,980 | $-450 | $-370 | $15,260 |
| Exchange Rate Effect | -10 | -20 | -10 | N/A | N/A |
| Beginning Cash Position | 760 | 980 | 170 | 410 | 7 |
| End Cash Position | 1,370 | 760 | 490 | 170 | 410 |
| Net Cash Flow | $600 | $-220 | $320 | $-240 | $410 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,370 | 3,630 | -260 | -4,400 | 450 |
| Free Cash Flow | 3,370 | 3,630 | -260 | -4,400 | 450 |